These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18832284)

  • 1. Low testosterone and the association with type 2 diabetes.
    Farrell JB; Deshmukh A; Baghaie AA
    Diabetes Educ; 2008; 34(5):799-806. PubMed ID: 18832284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
    Ogbera OA; Sonny C; Olufemi F; Wale A
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus.
    Ogbera AO
    West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach.
    Rice D; Brannigan RE; Campbell RK; Fine S; Jack L; Nelson JB; Regan-Klich J
    Diabetes Educ; 2008; 34 Suppl 5():97S-112S; quiz 113S-4S. PubMed ID: 19020265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.
    Liu CC; Wu WJ; Lee YC; Wang CJ; Ke HL; Li WM; Hsiao HL; Yeh HC; Li CC; Chou YH; Huang CH; Huang SP
    J Sex Med; 2009 Apr; 6(4):936-946. PubMed ID: 19210712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan.
    Al Hayek AA; Khawaja NM; Khader YS; Jaffal SK; Ajlouni KM
    J Diabetes Complications; 2014; 28(2):135-40. PubMed ID: 24388552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.
    Taylor SR; Meadowcraft LM; Williamson B
    Pharmacotherapy; 2015 Aug; 35(8):780-92. PubMed ID: 26289308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease.
    Dhindsa S; Reddy A; Karam JS; Bilkis S; Chaurasia A; Mehta A; Raja KP; Batra M; Dandona P
    Eur J Endocrinol; 2015 Sep; 173(3):359-66. PubMed ID: 26101371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex association between metabolic syndrome and male hypogonadism.
    Dimopoulou C; Goulis DG; Corona G; Maggi M
    Metabolism; 2018 Sep; 86():61-68. PubMed ID: 29656047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen deficit and diabetes].
    Cáp J
    Vnitr Lek; 2012 Mar; 58(3):228-31. PubMed ID: 22486290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism -an Integrated Diabetes and Endocrine Academy (IDEA) consensus guideline.
    Majumdar S; Mukherjee JJ; Ray S; Goswami S; Jude E; Biswas A; Hanumanthu A; John M; Sinha B; Ghoshal S; Kota S; Sharma SK; Jacob JJ
    Diabetes Metab Syndr; 2021; 15(4):102191. PubMed ID: 34245961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of androgen deficiency in men with erectile dysfunction.
    Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
    Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population.
    Anupam B; Shivaprasad C; Vijaya S; Sridevi A; Aiswarya Y; Nikhil K
    Diabetes Metab Syndr; 2020; 14(5):1299-1304. PubMed ID: 32755825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
    Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus.
    Arafa M; Zohdy W; Aboulsoud S; Shamloul R
    Andrologia; 2012 May; 44 Suppl 1():756-63. PubMed ID: 22211848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.